Ci-Tu MedScience

Medical Science Consulting Excellence

Ci-Tu MedScience GmbH delivers comprehensive medical scientific consulting services, combining deep scientific expertise with strategic insight to advance the initiatives of pharmaceutical companies and CROs.

Our Services

Comprehensive medical scientific consulting solutions tailored to the pharmaceutical companies and CROs

Clinical Development

Strategic, end-to-end leadership across clinical development and evidence generation—from study design and execution to regulatory alignment—delivering high-quality, submission-ready outputs.

RWD / RWE Generation

Strategic, end-to-end leadership for real-world evidence—from research question and study design to data sourcing, analytics, and regulatory alignment. To help teams generate decision-ready insights using fit-for-purpose methods and high-quality deliverables.

Pharmacovigilance

Strategic, end-to-end leadership and oversight of drug safety across the product lifecycle—from safety strategy to regulatory alignment, including assessment of safety data to identify, evaluate, and manage emerging safety signals.

Medical Affairs

Strategic leadership bridging clinical evidence and real-world practice—shaping scientific narrative, stakeholder engagement, and medical strategy across the product lifecycle. To support teams with high-level guidance and oversight to ensure medical plans are credible, compliant, and impact-focused.

Market Access

Evidence-based strategies for optimal market positioning and reimbursement

Strategic Consultancy

High-level guidance on therapeutic development and portfolio optimization

Coaching

Practical coaching for leaders and teams to improve decision-making, communication, and execution under uncertainty—plus high-level coaching for pharma executives, medical leaders, and life-science teams to sharpen scientific judgment and strategic thinking, turning complex evidence into clear decisions.

Digital Health Solutions

Strategic guidance and hands-on support to design, build, and scale digital health products—combining clinical insight, behavioral science, and data-driven development.

Dr. Çiğdem Türkmen

Leadership

Guided by deep scientific expertise and extensive pharmaceutical industry experience

Founder & Principal Consultant

Dr. Cigdem Turkmen, MD, Neurologist, MSc

Dr. Cigdem Turkmen is a medical science consultant specializing in Clinical Development, Medical Affairs, and Real-World Evidence (RWE) strategy. A board-certified neurologist with a Master's degree in Movement Disorders, she brings deep scientific rigor to pharmaceutical consulting.

Her robust industry background includes over 15 years of leadership at major global organizations such as Novartis, Merck, Abbott, and Roche. Throughout her career, she has successfully led global therapeutic area review committees, managed cross-functional matrix teams, and oversaw clinical trials across diverse regions.

Dr. Turkmen partners with pharmaceutical companies and CROs to optimize medical strategies, ensure GCP compliance, and accelerate evidence generation for complex therapeutic areas, including CNS and rare diseases.

Credentials

Board-Certified NeurologistMSc Movement DisordersAcademic Physician15+ Years Industry Leadership

Areas of Expertise

Clinical DevelopmentMedical AffairsGlobal Strategy DevelopmentRegulatory InteractionsProduct Lifecycle ManagementClinical TrialsClinical Study DesignGCPReal World Evidence (RWE)NeurologyNeuroscienceMovement DisordersParkinson's DiseaseNeuroimmunologyCNSPainPsychiatryRare DiseasesEpilepsy

Let's Work Together

Partner with Ci-Tu MedScience GmbH to advance your medical science initiatives with expert guidance and strategic insight.

Location

Basel, Switzerland

Send us a message